Pharmacogenetics of the organic anion transporting polypeptide 1A2

Pharmacogenomics

Volumn 10, Issue 3, 2009, Pages 339-344

  Franke, Ryan M ^a   Scherkenbach, Lisa A ^a   Sparreboom, Alex ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

Genetic variant; Inhibitor; OATP1A2; Pharmacogenetics; SLCO1A2; SNP; Substrate; Transporter

Indexed keywords

ADENOSINE; ALANINE; ARGININE; ASPARAGINE; ASPARTIC ACID; CYSTEINE; CYTOSINE; ESTRONE SULFATE; GLUTAMIC ACID; GUANINE; ISOLEUCINE; METHOTREXATE; ORGANIC ANION TRANSPORTER 1; PREGNANE X RECEPTOR; THYMINE; TYROSINE; ORGANIC ANION TRANSPORTER; SLCO1A2 PROTEIN, HUMAN;

AMINO ACID SUBSTITUTION; ARTICLE; DRUG ABSORPTION; DRUG DISPOSITION; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG PENETRATION; DRUG TRANSPORT; DRUG UPTAKE; ETHNIC DIFFERENCE; GENE EXPRESSION; GENE FREQUENCY; GENETIC VARIABILITY; HUMAN; NONHUMAN; PHARMACOGENETICS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; SINGLE NUCLEOTIDE POLYMORPHISM; TISSUE LEVEL; BLOOD BRAIN BARRIER; BRAIN CIRCULATION; CAPILLARY; ENVIRONMENT; GENETICS; HEPATOBILIARY SYSTEM; INTESTINE; METHODOLOGY; PHYSIOLOGY; REVIEW; VASCULAR ENDOTHELIUM;

BILIARY TRACT; BLOOD-BRAIN BARRIER; CAPILLARIES; CEREBROVASCULAR CIRCULATION; ENDOTHELIUM, VASCULAR; ENVIRONMENT; GENETIC VARIATION; HUMANS; INTESTINES; ORGANIC ANION TRANSPORT PROTEIN 1; ORGANIC ANION TRANSPORTERS; PHARMACOGENETICS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 65649132986     PISSN: 14622416     EISSN: 17448042     Source Type: Journal    
DOI: 10.2217/14622416.10.3.339     Document Type: Article

References (33)

1. Hediger MA, Romero MF, Peng JB, Rolfs A, Takanaga H, Bruford EA: The ABCs of solute carriers: physiological, pathological and therapeutic implications of human membrane transport proteinsIntroduction. Pflugers Arch. 447, 465-468 (2004).
2. Hagenbuch B, Meier PJ: Organic anion transporting polypeptides of the OATP/SLC21 family: phylogenetic classification as OATP/ SLCO superfamily, new nomenclature and molecular/functional properties. Pflugers Arch. 447, 653-665 (2004).
3. Hagenbuch B, Meier PJ: The superfamily of organic anion transporting polypeptides. Biochim. Biophys. Acta 1609, 1-18 (2003).
4. Tamai I, Nezu J, Uchino H et al.: Molecular identification and characterization of novel members of the human organic anion transporter (OATP) family. Biochem. Biophys. Res. Commun. 273, 251-260 (2000).
5. Kullak-Ublick CA, Ismair MG, Stieger B et al.: Organic anion-transporting polypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver. Gastroenterology 120, 525-533 (2001).
6. Fischer WJ, Altheimer S, Cattori V, Meier PJ, Dietrich DR, Hagenbuch B: Organic anion transporting polypeptides expressed in liver and brain mediate uptake of microcystin. Toxicol. Appl. Pharmacol. 203, 257-263 (2005).
7. Fujiwara K, Adachi H, Nishio T et al.: Identification of thyroid hormone transporters in humans: different molecules are involved in a tissue-specific manner. Endocrinology 142, 2005-2012 (2001).
8. Kullak-Ublick GA, Stieger B, Hagenbuch B, Meier PJ: Hepatic transport of bile salts. Semin. Liver Dis. 20, 273-292 (2000).
9. Kullak-Ublick GA, Hagenbuch B, Stieger B et al.: Molecular and functional characterization of an organic anion transporting polypeptide cloned from human liver. Gastroenterology 109, 1274-1282 (1995).
10. Kullak-Ublick GA, Fisch T, Oswald M et al.: Dehydroepiandrosterone sulfate (DHEAS): identification of a carrier protein in human liver and brain. FEBS Lett. 424, 173-176 (1998).
11. Gao B, Hagenbuch B, Kullak-Ublick GA, Benke D, Aguzzi A, Meier PJ: Organic anion-transporting polypeptides mediate transport of opioid peptides across blood-brain barrier. J Pharmacal. Exp. Ther. 294, 73-79 (2000).
12. Bossuyt X, Muller M, Meier PJ: Multispecific amphipathic substrate transport by an organic anion transporter of human liver. J. Hepatol. 25, 733-738 (1996).
13. Cvetkovic M, Leake B, Fromm MF, Wilkinson GR, Kim RB: OATP and P-glycoprotein transporters mediate the cellular uptake and excretion of fexofenadine. Drug Metab. Dispos. 27, 866-871 (1999).
14. van Montfoort JE, Muller M, Groothuis GM, Meijer DK, Koepsell H, Meier PJ: Comparison of 'type I' and 'type II' organic cation transport by organic cation transporters and organic anion- transporting polypeptides. J. Pharmacol. Exp. Ther. 298, 110-115 (2001).
15. van Montfoort JE, Hagenbuch B, Fattinger KE et al.: Polyspecific organic anion transporting polypeptides mediate hepatic . uptake of amphipathic type II organic cations. J. Pharmacol. Exp. Ther. 291, 147-152 (1999).
16. Lee W, Glaeser H, Smith LH et al.: Polymorphisms in human organic anion-transporting polypeptide 1A2 (OATP1A2): implications for altered drug disposition and central nervous system drug entry. J. Biol. Chem. 280, 9610-9617 (2005).
17. Briz O, Serrano MA, Rebollo N et al.: Carriers involved in targeting the cytostatic bile acid-cisplatin derivatives cis-diamminechloro-cholylglycinate-platinum (II) and cis-diammine-bisursodeoxycholate-platinum (II) toward liver cells. Mol. Pharmacol. 61, 853-860 (2002).
18. Hu S, Franke RM, Filipski KK et al.: Interaction of imatinib with human organic ion carriers. Clin. Cancer Res. 14, 3141-3148 (2008).
19. Franke RM, Sparreboom A: Inhibition of imatinib transport by uremic toxins during renal failure. J. Clin. Oncol. 26, 4226-4227; author reply 4227-4228 (2008).
20. Glaeser H, Bailey DG, Dresser GK et al.: Intestinal drug transporter expression and the impact of grapefruit juice in humans. Clin. Pharmacol. Ther. 81, 362-370 (2007).
21. Dresser GK, Bailey DG, Leake BF et al.: Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine. Clin. Pharmacol. Ther. 71, 11-20 (2002).
22. Vavricka SR, van Montfoort J, Ha HR, Meier PJ, Fattinger K: Interactions of rifamycin SV and rifampicin with organic anion uptake systems of human liver. Hepatology 36, 164-172 (2002).
23. Briz O, Serrano MA, Maclas RL, Gonzalez-Gallego J, Marin JJ: Role of organic anion-transporting polypeptides, OATP-A, OATP-C and OATP-8, in the human placenta-maternal liver tandem excretory pathway for foetal bilirubin. Biochem. J. 371, 897-905 (2003).
24. Steckelbroeck S, Nassen A, Ugele B et al.: Steroid sulfatase (STS) expression in the human temporal lobe: enzyme activity, mRNA expression and immunohistochemistry study. J. Neurochem. 89, 403-417 (2004).
25. Meier Y. Floranta JJ, Darimont J et al.: Regional distribution of solute carrier mRNA expression along the human intestinal tract. Drug Metab. Dispos. 35, 590-594 (2007).
26. Hilgendorf C, Ahlin C, Seithel A, Artursson P, Ungell AL, Karlsson J: Expression of thirty-six drug transporter genes in human intestine, liver, kidney, and organotypic cell lines. Drug Metab. Dispos. 35, 1333-1340 (2007).
27. Miki Y, Suzuki T, Kitada K et al.: Expression of the steroid and xenobiotic receptor and its possible target gene, organic anion transporting polypeptide-A, in human breast carcinoma. Cancer Res. 66, 535-542 (2006).
28. Pizzagalli F, Varga Z, Huber RD, Folkers G, Meier PJ, St-Pierre MV: Identification of steroid sulfate transport processes in the human mammary gland. J. Clin. Endocrinol. Metab. 88, 3902-3912 (2003).
29. Meyer zu Schwabedissen HE, Tirona RG, Yip CS, Ho RH, Kim RB: Interplay between the nuclear receptor pregnane X receptor and the uptake transporter organic anion transporter polypeptide 1A2 selectively enhances estrogen effects in breast cancer. Cancer Res. 68, 9338-9347 (2008).
30. Deeken JF, Figg WD, Bates SE, Sparreboom A: Toward individualized treatment: prediction of anticancer drug disposition and toxicity with pharmacogenetics. Anticancer Drugs 18, 111-126 (2007).
31. Zair ZM, Eloranta JJ, Stieger B, Kullak-Ublick CA: Pharmacogenetics of OATP (SLC21/SLC0), OAT and OCT (SLC22) and PEPT (SLC15) transporters in the intestine, liver and kidney. Pharmacogenomict 9, 597-624 (2008).
32. Iida A, Saito S, Sekine A et al.: Catalog of 258 single-nucleotide polymorphisms (SNPs) in genes encoding three organic anion transporters, three organic anion-transporting polypeptides, and three NADH:ubiquinone oxidoreductase flavoproteins. J. Hum. Genet. 46, 668-683 (2001).
33. Badagnani I, Castro RA, Taylor TR et al.: Interaction of methotrexate with organic-anion transporting polypeptide 1A2 and its genetic variants. J. Pharmacol. Exp. Ther. 318, 521-529 (2006).